Kan Liu

Kan LIU, MD, PhD

Associate Chief Physician | Associate Professor | Master's Supervisor
Department of Urology, Chinese PLA General Hospital Beijing, 28 Fuxing Rd, 100853, P.R. China

Education:

• Ph.D. (Urology), Chinese PLA Medical School (2016 – 2019)
• Joint PhD Training, Heidelberg University, Germany (2018 – 2019)
• Master of Surgery (Urology), Chinese PLA Medical School (2013 – 2016)
• Bachelor of Clinical Medicine, Fudan University (2008 – 2013)

Academic Appointments:

• Associate Chief Physician, Associate Professor, Department of Urology, Chinese PLA General Hospital (2022 – Present)
• Associate Professor, Chinese PLA Medical College (2024 – Present)
• Master's Supervisor, Chinese PLA General Hospital & Chinese PLA Medical College (2025 – Present)
• Attending Physician, Department of Urology, Chinese PLA General Hospital (2019 – 2022)

Specialties & Research Interests:

Minimally invasive surgery for urologic oncology; robotic and laparoscopic surgery for urological tumors, especially renal tumor; precise diagnosis and personalized therapy for renal cell carcinoma; renal cancer with venous tumor thrombus; immunotherapy resistance.

Academic Membership:

• Member, Robotics Group, Chinese Urological Association (CUA)
• Committee Member & Secretary, Renal Cancer Quality Control Committee, National Cancer Center
• Youth Member, Chinese-German Association of Urology (CGAU)
• Youth Committee Member, Beijing Cancer Prevention & Treatment Society

Awards & Honors:

• Military Science and Technology Progress Award, Second Class (2024)
• "Four Haves" Outstanding Civilian Personnel (2022, 2025)

Research Projects:

Principal Investigator

• National Natural Science Foundation of China (Youth Program) – CCR2 mediates T-cell differentiation and promotes resistance to PD-1 inhibitors in renal cell carcinoma with venous tumor thrombus (No. 82403839, 2025 – 2027)
• Youth Innovation Fund, Chinese PLA General Hospital – Novel copolymer-coated large-diameter metallic ureteral stents for post-traumatic ureteral stricture (No. 22QNFC008, 2023 – 2024)

Key Participation

• Sino-German Cooperation Project (M-0735)
• National Science and Technology Major Project (2026ZD0553706)
• 4 NSFC General Programs

Publications & Patent:

• 11 SCI papers (first/co-first author), total IF = 80.1
• 2 papers in European Urology (IF = 25.2, CAS Q1 TOP)
• 5 Chinese core journal papers
• 3 book chapters (Springer & People's Medical Publishing House)
• Over 100 surgical illustrations; multiple SCI journal covers
• Patent: National Invention Patent (First Inventor) – A laparoscopic surgical forceps (ZL 201811356416.1)

Academic & International Exchanges:

• 2024: Invited Speaker, 8th CGAU Annual Meeting, Heidelberg, Germany
• 2025: Operative Demonstration, Beijing Robotics & Laparoscopy Urology Congress